Medicines Co. Sues Dr. Reddy's Over Generic Angiomax
Medicines Co. claims that Dr. Reddy’s abbreviated new drug application infringes two patents for the drug, an injectable used to treat patients with unstable angina who are undergoing angioplasty.
This isn't the first time he Medicines Co. has gone to court to protect its Angiomax patents. In February, the company sued Mylan Inc. in Illinois to block...
To view the full article, register now.